Cover Image
Market Research Report
Product code 
1092244

Fractional Flow Reserve Market - Global Outlook & Forecast 2022-2027

Published: | Arizton Advisory & Intelligence | 287 Pages | Delivery time: 1-2 business days

Price

Back to Top
Fractional Flow Reserve Market - Global Outlook & Forecast 2022-2027
Published: June 20, 2022
Arizton Advisory & Intelligence
Content info: 287 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The global fractional flow reserve market is expected to grow at a CAGR of 12% during 2022-2027

The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing stent insertion, and the cost of the treatment. The benefits of FFR are high; however, its usage is limited in the market. The FFR is commonly used to decide the need for revascularization. The usage of non-invasive fractional flow reserve systems is increasing due to innovative methods in healthcare systems. As a part of the standard procedure to diagnose coronary artery disease (CAD), multiple non-invasive tests are performed on the patients complaining of stable chest pain and low or intermediate probability of CAD. Chest pain remains the second most common reason for adult emergency visits in the United States.

The increasing target population globally drives the demand for FFR systems.

The increasing target population will be a major driving factor for the usage of FFR in the market. Cardiovascular diseases cause one-third of deaths worldwide. Ischemic heart disease (IHD) is one of the prevalent conditions. The IHD incidence is expected to increase due to an increase in obesity, metabolic syndrome, diabetic conditions, and the aged population. In the past two decades, there has been a significant increase in the aging population. According to the United Nations, one in every eleven people will be over 65 years old by 2050, up from one in every eleven in 2019. In addition, reduced physical activity, rapid urbanization, and globalization activities in LMICs have led to an increase in cardiovascular diseases, including IHD. In countries like the United States, the cost of IHD is approaching 1%-1.5% of the gross domestic product (GDP); in the case of LMICs, it accounts for 10% of total per capita healthcare expenditure. This increasing target population globally will drive the global fractional flow reserve market growth.

Technological Advancements Driving the Faster adoption of FFR.

The fractional flow reserve market is experiencing high technological advancements with non-invasive FFR methods. This trend is augmenting the demand and adoption of next-generation FFR products among healthcare providers and end-users. The vendors such as Boston Scientific, Philips, and ACIST Medical Systems have launched the next-generation products in the market. Artificial intelligence (AI) and machine learning also played an essential role in giving real patient experiences with FFR products. In comparison with conventional methods, AI technology has helped the end-users analyze a large volume of cases in a shorter duration and provide equal quality treatment to all the patients irrespective of the number of patients diagnosed at the same time. The end-users adopt image-based techniques such as FFR-CT and FFRangio more frequently due to the non-invasive assessment of coronary lesions.

SEGMENT ANALYSIS

Technology

The invasive fractional flow reserve systems are widely accepted as a standard technique for assessing the lesion-specific ischemic in patients with 50% to 90% of stenosis. The advancement in the invasive segment is limited. For instance, in 2020, Philips launched the first solid core pressure guidewire for the coronary interventional procedure.

The number of people admitted to the CATH labs is decreasing in developed countries due to the change in better diagnostics of coronary artery disease. The non-invasive method is revolutionizing the cardiac diagnostic segment. The FFR-CT has helped reduce the number of patients referred for unnecessary catheterization. There are many scenarios in which the patient is recommended for stents and other procedures without proper quality data, where invasive FFR is ineffective in diagnosing the patient's condition. The FFR-CT (non-invasive) has proven to be better than the FFR invasive, seen as a gatekeeper for CATH Labs in the market.

Application

The technological advancements in the market have made the clinicians diagnose the patient with multivessel diseases, which is a complex scenario for the invasive methods in the market. Non-invasive methods provide the 3D structure of the heart with the FFR value and indicate the possible stenosis locations. This is a major revolutionary product to treat patients with multivessel diseases. There is a constant increase in people admitted to hospitals suffering from multivessel diseases, especially in developing and developed countries.

End-User

Hospitals & Specialty Cardiac Centers: Hospitals are the first point of contact for any patients, especially during the emergency conditions like chest pain. This increases the number of people preferring the hospitals to undergo treatments, and Hospitals do invest in the latest technologies to attract better customers in the region. Most elective surgeries and complex cardiac surgeries are performed in specialty cardiac centers.

Office-Based Labs: It is one of the new evolutions in the laboratory spaces. The movement of people and doctors away from the hospitals to get better attention, and safer and quickest treatments are driving the demand for the new labs like office-based labs in the market.

Diagnostic Imaging Centers predominantly invest in advanced products to attract customers; they partner with a large number of clinics and hospitals providing the services indirectly. They are expected to grow at a faster CAGR during the forecast period.

Segmentation by Technology*

  • Invasive
  • Non-Invasive

Segmentation by Applications

  • Single-Vessel
  • Multi-Vessel

Segmentation by End-Users*

  • Hospitals & Specialty Cardiac Centers
  • Office-Based Labs
  • Diagnostic Imaging Centers
  • Others

Geography

Many developed countries like the US are shifting from the volume-based to value-based approach in the healthcare systems. This is making the developed countries prefer advanced products like FFR-CT. Some European countries prefer using value-based products to enhance their quality of treatments, which is not the case with developing countries like India, China, Brazil, Mexico, and Turkey. Still, the preference is majorly for volume-based treatments, which are economical and provide results to treat the patients.

North America: The United States dominated the global fractional flow reserve market globally. The faster adoption of value-based products in the healthcare system, better awareness among the clinicians, and increasing adoption of FFR-CT has made the US a major fractional flow reserve market shareholder.

Europe: Europe healthcare is a mixture of both values-based and volume-based healthcare providers. The adoption is faster among the value-based treatment providers. The adoption of advanced technologies is low in some of the developing economies in Europe. The increasing number of CATH Labs and office-based labs are mainly driving the usage of advanced products and boosting the non-invasive fractional flow reserve market.

APAC: The adoption of advanced products like FFR is limited in the region. There is a constant increase in the number of cardiovascular disease patients in the region, and the number of people undergoing diagnostics is increasing. The demand for invasive methods is still high in the APAC region compared to non-invasive techniques. Due to its increased potential in the market, it is expected to grow at its highest during the forecast period.

Latin America: Latin American countries are also seen as famous destinations for various medical treatments. The adoption of advanced technologies is high in urban hospitals to attract tourists. Due to lack of reimbursement, the usage by local patients is limited, and they prefer undergoing more economic tests in the market. In addition, the lack of skilled lab technicians also limits the people to use conventional methods in the market.

Middle East & Africa: The middle east& Africa region is growing at a lower CAGR than other countries. As per the recently available data, there are more than 1.1 billion people in that region, but only 20 countries have CATH labs. The potential for FFR-based products is high in the market due to the increased target population. The fractional flow reserve market demand will increase with more economical products.

Segmentation by Geography*

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia

VENDOR ANALYSIS

Abbott, ACIST Medical Systems, Boston Scientific, CathWorks, General Electric Company, Koninklijke Philips, Opsens, and Siemens Healthineers are key players in the global fractional flow reserve market.

Vendors like HeartFlow are applying advanced methodologies to launch better products. Their technology uses the competitional fluid dynamics model, proper segmentation of coronaries, helping to find the value through the place of interest, and produces an interactive image with the FFR values for the doctors to make accurate decisions. In addition, one of the major benefits of this FFR-CT is that it avoids the invasive angiogram and provides better results comparatively. In addition, they are also using AI technology for better enhancement of the results and accuracy in diagnostics.

Key Vendors*

  • Abbott*
  • ACIST Medical Systems
  • Boston Scientific
  • CathWorks
  • General Electric Company
  • Koninklijke Philips
  • Opsens
  • Siemens Healthineers

KEY QUESTIONS ANSWERED

  • 1. What is the estimated value of the global fractional flow market?
  • 2. What is the growth rate of the global fractional flow market?
  • 3. Which region has the highest growth rate in the Fractional Flow Reserve Market?
  • 4. Which region has the largest Fractional Flow Reserve Market share globally?
  • 5. Who are the key players in the FFR market?
Product Code: Sample_Fractional Flow Reserve (FFR) Market - Global Outlook & Forecast 2022-2027_Arizton.pdf

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET BY TECHNOLOGY
    • 4.3.2 MARKET BY APPLICATIONS
    • 4.3.3 MARKET BY END-USER
    • 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 OVERVIEW
    • 7.1.1 CAD DIAGNOSIS
  • 7.2 FFR: AN OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

  • 8.1 NEXT-GEN DEVICES AUGMENTING NON-INVASIVE FFR METHODS
  • 8.2 FFR-OCT IMPROVING OUTCOMES IN DIABETIC PATIENTS
  • 8.3 AI & ML REVOLUTIONIZING FFR-CT

9 MARKET GROWTH ENABLERS

  • 9.1 NEW TECHNOLOGY DIRECTIONS IN FFR
  • 9.2 RISING PATIENT POPULATION OF CVDS
  • 9.3 INCREASING NUMBER OF CATH LABS

10 MARKET RESTRAINTS

  • 10.1 HIGH COST OF FFR
  • 10.2 TECHNICAL LIMITATIONS OF FFR
  • 10.3 LOWER ADOPTION OF FFR & RISE OF SUBSTITUTES

11 MARKET LANDSCAPE

  • 11.1 MARKET OVERVIEW
  • 11.2 MARKET SIZE & FORECAST
    • 11.2.1 GEOGRAPHY INSIGHTS
    • 11.2.2 TECHNOLOGY INSIGHTS
    • 11.2.3 APPLICATIONS INSIGHTS
    • 11.2.4 END-USER INSIGHTS
  • 11.3 FIVE FORCES ANALYSIS
    • 11.3.1 THREAT OF NEW ENTRANTS
    • 11.3.2 BARGAINING POWER OF SUPPLIERS
    • 11.3.3 BARGAINING POWER OF BUYERS
    • 11.3.4 THREAT OF SUBSTITUTES
    • 11.3.5 COMPETITIVE RIVALRY

12 TECHNOLOGY

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2 MARKET OVERVIEW
  • 12.3 NON-INVASIVE
    • 12.3.1 MARKET OVERVIEW
    • 12.3.2 MARKET SIZE & FORECAST
    • 12.3.3 NON-INVASIVE FFR BY GEOGRAPHY
  • 12.4 INVASIVE
    • 12.4.1 MARKET OVERVIEW
    • 12.4.2 MARKET SIZE & FORECAST
    • 12.4.3 INVASIVE FFR BY GEOGRAPHY

13 APPLICATIONS

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 SINGLE-VESSEL
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 SINGLE-VESSEL FFR BY GEOGRAPHY
  • 13.4 MULTI-VESSEL
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MULTI-VESSEL FFR BY GEOGRAPHY

14 END-USER

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 HOSPITALS & SPECIALTY CARDIAC CENTERS
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 HOSPITALS & SPECIALTY CARDIAC CENTERS SEGMENTATION BY GEOGRAPHY
  • 14.4 OFFICE-BASED LABS
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 OFFICE-BASED LABS FFR BY GEOGRAPHY
  • 14.5 DIAGNOSTIC IMAGING CENTERS
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 DIAGNOSTIC IMAGING CENTERS SEGMENTATION BY GEOGRAPHY
  • 14.6 OTHERS
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 OTHERS SEGMENTATION BY GEOGRAPHY

15 GEOGRAPHY

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

  • 16.1 MARKET OVERVIEW
  • 16.2 MARKET SIZE & FORECAST
    • 16.2.1 NORTH AMERICA BY TECHNOLOGY
    • 16.2.2 NORTH AMERICA BY APPLICATIONS SEGMENTATION
    • 16.2.3 NORTH AMERICA BY END-USERS
  • 16.3 KEY COUNTRIES
    • 16.3.1 US: MARKET SIZE & FORECAST
    • 16.3.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
    • 17.2.1 EUROPE BY TECHNOLOGY SEGMENTATION
    • 17.2.2 EUROPE BY APPLICATIONS SEGMENTATION
    • 17.2.3 EUROPE BY END-USER
  • 17.3 KEY COUNTRIES
    • 17.3.1 GERMANY: MARKET SIZE & FORECAST
    • 17.3.2 FRANCE: MARKET SIZE & FORECAST
    • 17.3.3 UK: MARKET SIZE & FORECAST
    • 17.3.4 ITALY: MARKET SIZE & FORECAST
    • 17.3.5 SPAIN: MARKET SIZE & FORECAST

18 APAC

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
    • 18.2.1 APAC BY TECHNOLOGY SEGMENTATION
    • 18.2.2 APAC BY APPLICATIONS SEGMENTATION
    • 18.2.3 APAC BY END-USER SEGMENTATION
  • 18.3 KEY COUNTRIES
    • 18.3.1 JAPAN: MARKET SIZE & FORECAST
    • 18.3.2 CHINA: MARKET SIZE & FORECAST
    • 18.3.3 INDIA: MARKET SIZE & FORECAST
    • 18.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 18.3.5 AUSTRALIA: MARKET SIZE & FORECAST

19 LATIN AMERICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
    • 19.2.1 LATIN AMERICA BY TECHNOLOGY SEGMENTATION
    • 19.2.2 LATIN AMERICA BY APPLICATION SEGMENTATION
    • 19.2.3 LATIN AMERICA BY END-USER SEGMENTATION
  • 19.3 KEY COUNTRIES
    • 19.3.1 BRAZIL: MARKET SIZE & FORECAST
    • 19.3.2 MEXICO: MARKET SIZE & FORECAST
    • 19.3.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
    • 20.2.1 MIDDLE EAST & AFRICA BY TECHNOLOGY SEGMENTATION
    • 20.2.2 MIDDLE EAST & AFRICA BY APPLICATIONS SEGMENTATION
    • 20.2.3 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
  • 20.3 KEY COUNTRIES
    • 20.3.1 TURKEY: MARKET SIZE & FORECAST
    • 20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

  • 21.1 COMPETITION OVERVIEW
  • 21.2 MARKET SHARE ANALYSIS
    • 21.2.1 ABBOTT
    • 21.2.2 ACIST MEDICAL SYSTEM
    • 21.2.3 BOSTON SCIENTIFIC
    • 21.2.4 CATHWORKS
    • 21.2.5 GE HEALTHCARE
    • 21.2.6 KONINKLIJKE PHILIPS
    • 21.2.7 OPSENS
    • 21.2.8 SIEMENS HEALTHINEERS

22 KEY COMPANY PROFILES

  • 22.1 ABBOTT
    • 22.1.1 BUSINESS OVERVIEW
    • 22.1.2 PRODUCT OFFERINGS
    • 22.1.3 KEY STRATEGIES
    • 22.1.4 KEY STRENGTHS
    • 22.1.5 KEY OPPORTUNITIES
  • 22.2 ACIST MEDICAL SYSTEMS
    • 22.2.1 BUSINESS OVERVIEW
    • 22.2.2 PRODUCT OFFERINGS
    • 22.2.3 KEY STRATEGIES
    • 22.2.4 KEY STRENGTHS
    • 22.2.5 KEY OPPORTUNITIES
  • 22.3 BOSTON SCIENTIFIC
    • 22.3.1 BUSINESS OVERVIEW
    • 22.3.2 PRODUCT OFFERINGS
    • 22.3.3 KEY STRATEGIES
    • 22.3.4 KEY STRENGTHS
    • 22.3.5 KEY OPPORTUNITIES
  • 22.4 CATHWORKS
    • 22.4.1 BUSINESS OVERVIEW
    • 22.4.2 PRODUCT OFFERINGS
    • 22.4.3 KEY STRATEGIES
    • 22.4.4 KEY STRENGTHS
    • 22.4.5 KEY OPPORTUNITIES
  • 22.5 GE HEALTHCARE
    • 22.5.1 BUSINESS OVERVIEW
    • 22.5.2 PRODUCT OFFERINGS
    • 22.5.3 KEY STRATEGIES
    • 22.5.4 KEY STRENGTHS
    • 22.5.5 KEY OPPORTUNITIES
  • 22.6 KONINKLIJKE PHILIPS
    • 22.6.1 BUSINESS OVERVIEW
    • 22.6.2 PRODUCT OFFERINGS
    • 22.6.3 KEY STRATEGIES
    • 22.6.4 KEY STRENGTHS
    • 22.6.5 KEY OPPORTUNITIES
  • 22.7 OPSENS
    • 22.7.1 BUSINESS OVERVIEW
    • 22.7.2 PRODUCT OFFERINGS
    • 22.7.3 KEY STRATEGIES
    • 22.7.4 KEY STRENGTHS
    • 22.7.5 KEY OPPORTUNITIES
  • 22.8 SIEMENS HEALTHINEERS
    • 22.8.1 BUSINESS OVERVIEW
    • 22.8.2 PRODUCT OFFERINGS
    • 22.8.3 KEY STRATEGIES
    • 22.8.4 KEY STRENGTHS
    • 22.8.5 KEY OPPORTUNITIES

23 REPORT SUMMARY

  • 23.1 KEY TAKEAWAYS
  • 23.2 STRATEGIC RECOMMENDATIONS

24 QUANTITATIVE SUMMARY

  • 24.1 TECHNOLOGY
    • 24.1.1 NORTH AMERICA BY TECHNOLOGY SEGMENTATION
    • 24.1.2 EUROPE BY TECHNOLOGY SEGMENTATION
    • 24.1.3 APAC BY TECHNOLOGY SEGMENTATION
    • 24.1.4 LATIN AMERICA BY TECHNOLOGY SEGMENTATION
    • 24.1.5 MIDDLE EAST & AFRICA BY TECHNOLOGY SEGMENTATION
  • 24.2 APPLICATION
    • 24.2.1 NORTH AMERICA BY APPLICATION SEGMENTATION
    • 24.2.2 EUROPE BY APPLICATION SEGMENTATION
    • 24.2.3 APAC BY APPLICATION SEGMENTATION
    • 24.2.4 LATIN AMERICA BY APPLICATIONS SEGMENTATION
    • 24.2.5 MIDDLE EAST & AFRICA BY APPLICATION SEGMENTATION
  • 24.3 END-USER
    • 24.3.1 NORTH AMERICA BY END-USER SEGMENTATION
    • 24.3.2 EUROPE BY END-USER SEGMENTATION
    • 24.3.3 APAC BY END-USER SEGMENTATION
    • 24.3.4 LATIN AMERICA BY END-USER SEGMENTATION
    • 24.3.5 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
  • 24.4 GEOGRAPHY
    • 24.4.1 INVASIVE SEGMENTATION BY GEOGRAPHY
    • 24.4.2 NON-INVASIVE SEGMENTATION BY GEOGRAPHY
    • 24.4.3 SINGLE-VESSEL SEGMENTATION BY GEOGRAPHY
    • 24.4.4 MULTI-VESSEL SEGMENTATION BY GEOGRAPHY
    • 24.4.5 HOSPITALS & SPECIALTY CARDIAC CENTERS SEGMENTATION BY GEOGRAPHY
    • 24.4.6 OFFICE-BASED LABS SEGMENTATION BY GEOGRAPHY
    • 24.4.7 DIAGNOSTIC IMAGING CENTERS SEGMENTATION BY GEOGRAPHY
    • 24.4.8 OTHERS SEGMENTATION BY GEOGRAPHY

25 APPENDIX

  • 25.1 ABBREVIATIONS

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL FRACTIONAL FLOW RESERVE (FFR) MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 IMPACT OF NEXT-GEN DEVICES AUGMENTING NON-INVASIVE FFR METHODS
  • EXHIBIT 4 ACIST RXI MINI SYSTEM FEATURES
  • EXHIBIT 5 IMPACT OF FFR-OCT IMPROVING OUTCOMES IN DIABETIC PATIENTS
  • EXHIBIT 6 GLOBAL INCREASE OF TARGET POPULATION
  • EXHIBIT 7 IMPACT OF AI & ML REVOLUTIONIZING FFR-CT
  • EXHIBIT 8 IMPACT OF NEW TECHNOLOGY DIRECTIONS IN FFR
  • EXHIBIT 9 IMPACT OF RISING PATIENT POPULATION OF CVDS
  • EXHIBIT 10 INDICATIONS FOR FFR MANAGEMENT
  • EXHIBIT 11 IMPACT OF INCREASING NUMBER OF CATH LABS
  • EXHIBIT 12 HOSPITALS WITH CATHETERIZATION LABORATORIES AND ON-SITE CARDIAC SURGERY PER MILLION PEOPLE
  • EXHIBIT 13 IMPACT OF HIGH COST OF FFR
  • EXHIBIT 14 IMPACT OF TECHNICAL LIMITATIONS OF FFR
  • EXHIBIT 15 IMPACT OF LOWER ADOPTION OF FFR & RISE OF SUBSTITUTES
  • EXHIBIT 16 GLOBAL FFR MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 17 GLOBAL FFR MARKET BY GEOGRAPHY (% SHARE)
  • EXHIBIT 18 GLOBAL FFR MARKET BY TECHNOLOGY (% SHARE)
  • EXHIBIT 19 GLOBAL FFR MARKET BY APPLICATIONS (% SHARE)
  • EXHIBIT 20 GLOBAL FFR MARKET BY END-USERS (% SHARE)
  • EXHIBIT 21 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 22 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 23 GLOBAL FFR BY TECHNOLOGY
  • EXHIBIT 24 GLOBAL FFR MARKET BY TECHNOLOGY: OVERVIEW
  • EXHIBIT 25 GLOBAL FFR MARKET BY TECHNOLOGY: INCREMENTAL GROWTH
  • EXHIBIT 26 GLOBAL FFR MARKET BY TECHNOLOGY: ABSOLUTE GROWTH
  • EXHIBIT 27 GROWTH ANALYSIS: GLOBAL FFR MARKET BY TECHNOLOGY
  • EXHIBIT 28 GLOBAL FFR MARKET BY NON-INVASIVE: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 29 GLOBAL NON-INVASIVE FFR MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 30 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 31 GLOBAL INVASIVE FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 32 GLOBAL INVASIVE FFR MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 34 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
  • EXHIBIT 35 GLOBAL FFR MARKET BY APPLICATIONS
  • EXHIBIT 36 GLOBAL FFR MARKET BY APPLICATION: OVERVIEW
  • EXHIBIT 37 GLOBAL FFR MARKET BY APPLICATIONS: INCREMENTAL GROWTH
  • EXHIBIT 38 GLOBAL FFR MARKET BY APPLICATIONS: ABSOLUTE GROWTH
  • EXHIBIT 39 GLOBAL SINGLE-VESSEL FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 40 GLOBAL SINGLE-VESSEL FFR MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 41 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 42 GLOBAL MULTI-VESSEL FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 43 GLOBAL MULTI-VESSEL FFR MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 44 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 45 INCREMENTAL GROWTH BY END-USERS 2021 & 2027
  • EXHIBIT 46 GLOBAL FFR MARKET BY END-USER
  • EXHIBIT 47 GLOBAL FFR MARKET BY END-USER: OVERVIEW
  • EXHIBIT 48 GLOBAL FFR MARKET BY END-USERS: INCREMENTAL GROWTH
  • EXHIBIT 49 GLOBAL FFR MARKET BY END-USERS: ABSOLUTE GROWTH
  • EXHIBIT 50 GROWTH ANALYSIS: FFR MARKET BY END-USER
  • EXHIBIT 51 GLOBAL FFR MARKET BY HOSPITALS & SPECIALTY CARDIAC CENTERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 52 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 54 GLOBAL FFR MARKET BY OFFICE-BASED LABS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 55 GLOBAL OFFICE-BASED LABS IN FFR MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 57 GLOBAL FFR MARKET BY DIAGNOSTIC IMAGING CENTERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 58 GLOBAL FFR MARKET BY DIAGNOSTIC IMAGING CENTERS 2021-2027 ($ MILLION)
  • EXHIBIT 59 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 60 GLOBAL FFR MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 61 GLOBAL FFR MARKET BY OTHER END-USERS 2021-2027 ($ MILLION)
  • EXHIBIT 62 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 64 GLOBAL FFR MARKET BY GEOGRAPHY
  • EXHIBIT 65 GLOBAL FFR MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
  • EXHIBIT 66 GLOBAL FFR MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
  • EXHIBIT 67 FFR MARKET IN NORTH AMERICA: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 68 NORTH AMERICA FFR MARKET: KEY COUNTRIES
  • EXHIBIT 69 FFR MARKET IN NORTH AMERICA 2021-2027 ($ MILLION)
  • EXHIBIT 70 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 71 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
  • EXHIBIT 72 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 73 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 74 FRACTIONAL FLOW RESERVE MARKET IN THE US 2021-2027 ($ MILLION)
  • EXHIBIT 75 FFR MARKET IN CANADA 2021-2027 ($ MILLION)
  • EXHIBIT 76 CANADIAN RISKY LIFESTYLE PRACTICES
  • EXHIBIT 77 FFR MARKET IN EUROPE: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 78 HOSPITALS WITH 24/7 CATH LABS PER MILLION IN EUROPE
  • EXHIBIT 79 EUROPE FFR MARKET: KEY COUNTRIES
  • EXHIBIT 80 FFR MARKET IN EUROPE 2021-2027 ($ MILLION)
  • EXHIBIT 81 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 82 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
  • EXHIBIT 83 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 84 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 85 FFR MARKET IN GERMANY 2021-2027 ($ MILLION)
  • EXHIBIT 86 FFR MARKET IN FRANCE 2021-2027 ($ MILLION)
  • EXHIBIT 87 FFR MARKET IN UK 2021-2027 ($ MILLION)
  • EXHIBIT 88 FFR MARKET IN ITALY 2021-2027 ($ MILLION)
  • EXHIBIT 89 FFR MARKET IN SPAIN 2021-2027 ($ MILLION)
  • EXHIBIT 90 FFR MARKET IN APAC: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 91 FFR MARKET IN APAC: KEY COUNTRIES
  • EXHIBIT 92 FFR MARKET IN APAC 2021-2027 ($ MILLION)
  • EXHIBIT 93 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 94 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
  • EXHIBIT 95 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 96 INCREMENTAL GROWTH IN APAC 2021 & 2027
  • EXHIBIT 97 FFR MARKET IN JAPAN 2021-2027 ($ MILLION)
  • EXHIBIT 98 FFR MARKET IN CHINA 2021-2027 ($ MILLION)
  • EXHIBIT 99 FFR MARKET IN INDIA 2021-2027 ($ MILLION)
  • EXHIBIT 100 FFR MARKET IN SOUTH KOREA 2021-2027 ($ MILLION)
  • EXHIBIT 101 FFR MARKET IN AUSTRALIA 2021-2027 ($ MILLION)
  • EXHIBIT 102 FFR MARKET IN LATIN AMERICA: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 103 LATIN AMERICA FFR MARKET: KEY COUNTRIES
  • EXHIBIT 104 FFR MARKET IN LATIN AMERICA 2021-2027 ($ MILLION)
  • EXHIBIT 105 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 106 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
  • EXHIBIT 107 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
  • EXHIBIT 109 FRACTIONAL FLOW RESERVE MARKET IN BRAZIL 2021-2027 ($ MILLION)
  • EXHIBIT 110 FFR MARKET IN MEXICO 2021-2027 ($ MILLION)
  • EXHIBIT 111 FFR MARKET IN ARGENTINA 2021-2027 ($ MILLION)
  • EXHIBIT 112 MIDDLE EAST & AFRICA FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 113 MIDDLE EAST & AFRICA FFR MARKET: KEY COUNTRIES
  • EXHIBIT 114 FFR MARKET IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • EXHIBIT 115 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 116 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
  • EXHIBIT 117 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 118 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 119 FFR MARKET IN TURKEY 2021-2027 ($ MILLION)
  • EXHIBIT 120 FFR MARKET IN SAUDI ARABIA 2021-2027 ($ MILLION)
  • EXHIBIT 121 FFR MARKET IN SOUTH AFRICA 2021-2027 ($ MILLION)
  • EXHIBIT 122 PURE& DIVERSIFIED COMPANIES IN GLOBAL FFR MARKET
  • EXHIBIT 123 GLOBAL FFR MARKET: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 124 VENDORS IN GLOBAL FFR MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
  • EXHIBIT 125 ABBOTT: TOTAL REVENUE 2019-2021 ($ MILLIONS)
  • EXHIBIT 126 ABBOTT: R&D EXPENDITURE 2019-2021 ($ MILLIONS)
  • EXHIBIT 127 ABBOTT: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
  • EXHIBIT 128 ABBOTT: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)
  • EXHIBIT 129 BOSTON SCIENTIFIC: TOTAL REVENUE 2019-2021 ($ MILLIONS)
  • EXHIBIT 130 BOSTON SCIENTIFIC: R&D EXPENDITURE 2019-2021 ($ MILLIONS)
  • EXHIBIT 131 BOSTON SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
  • EXHIBIT 132 BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)
  • EXHIBIT 133 GE HEALTHCARE: TOTAL REVENUE 2019-2021 ($ MILLIONS)
  • EXHIBIT 134 GE HEALTHCARE: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
  • EXHIBIT 135 GE HEALTHCARE: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)
  • EXHIBIT 136 KONINKLIJKE PHILIPS: TOTAL REVENUE 2019-2021 ($ MILLIONS)
  • EXHIBIT 137 KONINKLIJKE PHILIPS: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
  • EXHIBIT 138 OPSENS: TOTAL REVENUE 2019-2021 ($ MILLIONS)
  • EXHIBIT 139 OPSENS: R&D EXPENDITURE 2019-2021 ($ MILLIONS)
  • EXHIBIT 140 SIEMENS HEALTHINEERS: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 141 SIEMENS HEALTHINEERS: R&D SPENDING 2019-2021 ($ MILLION)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 TREATMENT FOR CORONARY ARTERY DISEASE
  • TABLE 4 EXAMPLES OF NEXT-GENERATION FFR PRESSURE WIRE CHARACTERISTICS
  • TABLE 5 COMPARISON OF IMAGE-DERIVED FFR SYSTEM
  • TABLE 6 APPROXIMATE COSTING FOR STAGES IN FFR CT
  • TABLE 7 FFR PRESSURE GUIDEWIRE FAILURE AND ASSOCIATED ADVERSE EVENTS COMPARISON AMONG DIFFERENT GUIDEWIRES
  • TABLE 8 GLOBAL NON-INVASIVE FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 9 GLOBAL NON-INVASIVE FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 10 COMPARISON OF INVASIVE FFR MONITORING METHODS WITH SPECIFICATIONS
  • TABLE 11 GLOBAL INVASIVE FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 12 GLOBAL INVASIVE FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 13 GLOBAL SINGLE-VESSEL FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 14 SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 15 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 16 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 17 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 18 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 19 OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 20 OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 21 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 22 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 23 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 24 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 25 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 ($ MILLION)
  • TABLE 26 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 (%)
  • TABLE 27 FFR MARKET BY APPLICATIONS IN NORTH AMERICA 2021-2027 ($ MILLION)
  • TABLE 28 FFR MARKET BY APPLICATIONS IN NORTH AMERICA 2021-2027 (%)
  • TABLE 29 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 ($ MILLION)
  • TABLE 30 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 (%)
  • TABLE 31 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 ($ MILLION)
  • TABLE 32 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 (%)
  • TABLE 33 FFR MARKET BY APPLICATIONS IN EUROPE 2021-2027 ($ MILLION)
  • TABLE 34 FFR MARKET BY APPLICATIONS IN EUROPE 2021-2027 (%)
  • TABLE 35 FFR MARKET BY END-USER IN EUROPE 2021-2027 ($ MILLION)
  • TABLE 36 FFR MARKET BY END-USER IN EUROPE 2021-2027 (%)
  • TABLE 37 PREVALENCE OF CVD AND ITS SUBTYPE IN PATIENTS WITH TYPE 2 DIABETES IN ITALY (%)
  • TABLE 38 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 ($ MILLION)
  • TABLE 39 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 (%)
  • TABLE 40 FFR MARKET BY APPLICATIONS IN APAC 2021-2027 ($ MILLION)
  • TABLE 41 FFR MARKET BY APPLICATIONS IN APAC 2021-2027 (%)
  • TABLE 42 FFR MARKET BY END-USER IN APAC 2021-2027 ($ MILLION)
  • TABLE 43 FFR MARKET BY END-USER IN APAC 2021-2027 (%)
  • TABLE 44 KOREAN ADULTS WITH CARDIOVASCULAR RISK FACTORS
  • TABLE 45 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 ($ MILLION)
  • TABLE 46 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 (%)
  • TABLE 47 FFR MARKET BY APPLICATIONS IN LATIN AMERICA 2021-2027 ($ MILLION)
  • TABLE 48 FFR MARKET BY APPLICATIONS IN LATIN AMERICA 2021-2027 (%)
  • TABLE 49 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 ($ MILLION)
  • TABLE 50 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 (%)
  • TABLE 51 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • TABLE 52 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 (%)
  • TABLE 53 FFR MARKET BY APPLICATIONS IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • TABLE 54 FFR MARKET BY APPLICATIONS IN MIDDLE EAST & AFRICA 2021-2027 (%)
  • TABLE 55 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • TABLE 56 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 (%)
  • TABLE 57 ABBOTT: MAJOR PRODUCT OFFERINGS
  • TABLE 58 ACIST MEDICAL SYSTEM: MAJOR PRODUCT OFFERINGS
  • TABLE 59 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS
  • TABLE 60 CATHWORKS: MAJOR PRODUCT OFFERINGS
  • TABLE 61 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 62 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
  • TABLE 63 OPSENS: MAJOR PRODUCT OFFERINGS
  • TABLE 64 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
  • TABLE 65 GLOBAL FFR MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
  • TABLE 66 GLOBAL FFR MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 67 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 ($ MILLION)
  • TABLE 68 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 (%)
  • TABLE 69 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 ($ MILLION)
  • TABLE 70 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 (%)
  • TABLE 71 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 ($ MILLION)
  • TABLE 72 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 (%)
  • TABLE 73 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 ($ MILLION)
  • TABLE 74 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 (%)
  • TABLE 75 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • TABLE 76 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 (%)
  • TABLE 77 GLOBAL FFR MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 78 GLOBAL FFR MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 79 FFR MARKET BY APPLICATION IN NORTH AMERICA 2021-2027 ($ MILLION)
  • TABLE 80 FFR MARKET BY APPLICATION IN NORTH AMERICA 2021-2027 (%)
  • TABLE 81 FFR MARKET BY APPLICATION IN EUROPE 2021-2027 ($ MILLION)
  • TABLE 82 FFR MARKET BY APPLICATION IN EUROPE 2021-2027 (%)
  • TABLE 83 FFR MARKET BY APPLICATION IN APAC 2021-2027 ($ MILLION)
  • TABLE 84 FFR MARKET BY APPLICATION IN APAC 2021-2027 (%)
  • TABLE 85 FFR MARKET BY APPLICATION IN LATIN AMERICA 2021-2027 ($ MILLION)
  • TABLE 86 FFR MARKET BY APPLICATION IN LATIN AMERICA 2021-2027 (%)
  • TABLE 87 FFR MARKET BY APPLICATION IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • TABLE 88 FFR MARKET BY APPLICATION IN MIDDLE EAST & AFRICA 2021-2027 (%)
  • TABLE 89 GLOBAL FFR MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 90 GLOBAL FFR MARKET BY END-USER 2021-2027 (%)
  • TABLE 91 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 ($ MILLION)
  • TABLE 92 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 (%)
  • TABLE 93 FFR MARKET BY END-USER IN EUROPE 2021-2027 ($ MILLION)
  • TABLE 94 FFR MARKET BY END-USER IN EUROPE 2021-2027 (%)
  • TABLE 95 FFR MARKET BY END-USER IN APAC 2021-2027 ($ MILLION)
  • TABLE 96 FFR MARKET BY END-USER IN APAC 2021-2027 (%)
  • TABLE 97 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 ($ MILLION)
  • TABLE 98 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 (%)
  • TABLE 99 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • TABLE 100 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 (%)
  • TABLE 101 GLOBAL FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 102 GLOBAL FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 103 INVASIVE IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 104 INVASIVE IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 105 NON-INVASIVE IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 106 NON-INVASIVE IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 107 GLOBAL SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 108 GLOBAL SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 109 GLOBAL MULTI-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 110 GLOBAL MULTI-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 111 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 112 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 113 GLOBAL OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 114 GLOBAL OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 115 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 116 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 117 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 118 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)